Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Myofibroblast in Kidney Fibrosis: Origin, Activation, and Regulation
Qian Yuan, Roderick J. Tan, Youhua Liu
Advances in experimental medicine and biology (2019), pp. 253-283
Closed Access | Times Cited: 160

Showing 1-25 of 160 citing articles:

Kidney fibrosis: from mechanisms to therapeutic medicines
Rongshuang Huang, Ping Fu, Liang Ma
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 260
Targeting fibrosis: mechanisms and clinical trials
Manyu Zhao, Liqun Wang, Mengzhu Wang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 249
Signaling pathways of chronic kidney diseases, implications for therapeutics
Qian Yuan, Ben Tang, Chun Zhang
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 217
The fibrogenic niche in kidney fibrosis: components and mechanisms
Li Li, Haiyan Fu, Youhua Liu
Nature Reviews Nephrology (2022) Vol. 18, Iss. 9, pp. 545-557
Closed Access | Times Cited: 211
Cellular mechanotransduction in health and diseases: from molecular mechanism to therapeutic targets
Xingpeng Di, Xiaoshuai Gao, Liao Peng, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 160
Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys
Sheng Zhao, Wei Li, Weimin Yu, et al.
Theranostics (2021) Vol. 11, Iss. 18, pp. 8660-8673
Open Access | Times Cited: 110
A Klotho-derived peptide protects against kidney fibrosis by targeting TGF-β signaling
Qian Yuan, Qian Ren, Li Li, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 101
AKI: an increasingly recognized risk factor for CKD development and progression
Johanna T. Kurzhagen, Sergio Dellepiane, Vincenzo Cantaluppi, et al.
Journal of Nephrology (2020) Vol. 33, Iss. 6, pp. 1171-1187
Closed Access | Times Cited: 133
Value of [68Ga]Ga-FAPI-04 imaging in the diagnosis of renal fibrosis
Yue Zhou, Xin Yang, Huipan Liu, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2021) Vol. 48, Iss. 11, pp. 3493-3501
Open Access | Times Cited: 84
Cellular Senescence in Kidney Fibrosis: Pathologic Significance and Therapeutic Strategies
Jie Xu, Lili Zhou, Youhua Liu
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 73
Indoxyl Sulfate, a Tubular Toxin, Contributes to the Development of Chronic Kidney Disease
Tong-Hong Cheng, Ming-Chieh Ma, Min-Tser Liao, et al.
Toxins (2020) Vol. 12, Iss. 11, pp. 684-684
Open Access | Times Cited: 71
Oxidatively stressed extracellular microenvironment drives fibroblast activation and kidney fibrosis
Li Li, Meizhi Lu, Yiling Peng, et al.
Redox Biology (2023) Vol. 67, pp. 102868-102868
Open Access | Times Cited: 28
Macrophage promotes fibroblast activation and kidney fibrosis by assembling a vitronectin-enriched microenvironment
Yiling Peng, Li Li, Jingyue Shang, et al.
Theranostics (2023) Vol. 13, Iss. 11, pp. 3897-3913
Open Access | Times Cited: 24
Role of mitochondria in pathogenesis and therapy of renal fibrosis
Xiaodong Zhao, Yunkuo Li, Jinyu Yu, et al.
Metabolism (2024) Vol. 155, pp. 155913-155913
Closed Access | Times Cited: 15
WWP2 Regulates Renal Fibrosis and the Metabolic Reprogramming of Profibrotic Myofibroblasts
Huimei Chen, Ran You, Jing Guo, et al.
Journal of the American Society of Nephrology (2024) Vol. 35, Iss. 6, pp. 696-718
Open Access | Times Cited: 10
Sirtuin 3 Activation by Honokiol Decreases Unilateral Ureteral Obstruction-Induced Renal Inflammation and Fibrosis via Regulation of Mitochondrial Dynamics and the Renal NF-κB-TGF-β1/Smad Signaling Pathway
Yi Quan, Woong Park, Jixiu Jin, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 2, pp. 402-402
Open Access | Times Cited: 63
The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases
Zhao Liu, Roderick J. Tan, Youhua Liu
Biomolecules (2020) Vol. 10, Iss. 6, pp. 960-960
Open Access | Times Cited: 60
Targeted apoptosis of myofibroblasts by elesclomol inhibits hypertrophic scar formation
Yi Feng, Jun‐Jie Wu, Zi‐Li Sun, et al.
EBioMedicine (2020) Vol. 54, pp. 102715-102715
Open Access | Times Cited: 57
Emerging Therapeutic Strategies for Attenuating Tubular EMT and Kidney Fibrosis by Targeting Wnt/β-Catenin Signaling
Lichao Hu, Mengyuan Ding, Weichun He
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 31
MSC-derived sEV-loaded hyaluronan hydrogel promotes scarless skin healing by immunomodulation in a large skin wound model
Sen Yang, Huan Jiang, Meng Qian, et al.
Biomedical Materials (2022) Vol. 17, Iss. 3, pp. 034104-034104
Closed Access | Times Cited: 29
Natural products in traditional Chinese medicine: molecular mechanisms and therapeutic targets of renal fibrosis and state-of-the-art drug delivery systems
Li Song, Wei Zhang, Shiyun Tang, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 170, pp. 116039-116039
Open Access | Times Cited: 20
YAP/TAZ: Molecular pathway and disease therapy
Yuzi Wei, Victoria Lee Zhi Hui, Yilin Chen, et al.
MedComm (2023) Vol. 4, Iss. 4
Open Access | Times Cited: 19
Renal Fibrosis: Mechanisms and Therapies
Bi‐Cheng Liu, Hui Y. Lan, Lin‐Li Lv
Advances in experimental medicine and biology (2019)
Closed Access | Times Cited: 54
TGF-β in Renal Fibrosis: Triumphs and Challenges
Yue-Yu Gu, Xusheng Liu, Xiao‐Ru Huang, et al.
Future Medicinal Chemistry (2020) Vol. 12, Iss. 9, pp. 853-866
Closed Access | Times Cited: 44
Astragalus and its formulas as a therapeutic option for fibrotic diseases: Pharmacology and mechanisms
Yi Zhu, Yilu Chai, Guojin Xiao, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top